AOD-9604
LipolysisModified HGH(176-191) C-terminal fragment studied for fat oxidation without raising GH or IGF-1.
AOD-9604 is the tail end of the growth hormone molecule — the specific fragment responsible for GH's fat-burning action, snipped away from the parts that raise blood sugar or grow tissue. The idea is to get GH's lipolytic (fat-releasing) effect without elevating GH or IGF-1 at all, so none of the growth-related risks apply. In practice the fat-loss effect is modest and the human data is thin, but its very clean safety profile makes it a low-stakes option, and there are early hints of joint and cartilage benefit too.
- Dose
- 300 mcg subQ daily, AM fasted.
- Reconstitute
- 10 mg + 2 mL = 5 mg/mL. 6 units = 300 mcg.
- Schedule
- 5–6×/week, 12+ week cycles.
- Half-life
- ~30 minutes.
- Timing
- AM fasted, 30 min before food.
- Risks
- Very mild. Some users report nausea.
Educational reference — not medical advice. Many peptides are not approved for the uses discussed; verify status in your jurisdiction and decide anything here with a qualified clinician.
within Growth Hormone — Direct Anabolic